期刊
TRENDS IN CELL BIOLOGY
卷 25, 期 5, 页码 249-264出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2014.12.004
关键词
bone morphogenetic proteins; antagonist; miRNA; Gremlin; disease
类别
资金
- Diabetes UK
- Northern Ireland Kidney Research Fund
- DEL Northern Ireland
- BBSRC CASE PhD studentship
- Irish Research Council for Science, Engineering, and Technology PhD programme in Bioinformatics and Systems Biology
- Science Foundation Ireland
- NIDDK Diabetes Complications Consortium
- Roche Pharmaceuticals, Basel
Bone morphogenetic proteins (BMPs) are secreted extracellular matrix (ECM)-associated proteins that regulate a wide range of developmental processes, including limb and kidney formation. A critical element of BMP regulation is the presence of secreted antagonists that bind and inhibit BMP binding to their cognate Ser/Thr kinase receptors at the plasma membrane. Antagonists such as Noggin, Chordin, Gremlin (Grem1), and twisted gastrulation-1 (Twsg1) have been shown to inhibit BMP action in a range of different cell types and developmental stage-specific contexts. Here we review new developments in the field of BMP and BMP antagonist biology during mammalian development and suggest strategies for targeting these proteins in human disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据